UTILISATION D'UREIDOMUSTINE (BO-1055) DANS LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

MEMORIAL SLOAN KETTERING CANCER CENTER;ACADEMIA SINICA

发明人:

MOORE, MALCOLM,SHIEH, JAE-HUNG,SU, TSANN-LONG,LEE, TE-CHANG

申请号：

CA2994009

公开号：

CA2994009A1

申请日:

2016.08.17

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

Method of using ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in the treatment of a cancer, selected from the group consisting of various types of human leukemia [such as acute myeloid leukemia (ALL) and acute B Lymphoblastic leukemia (B-ALL)], lymphomas, small lung cell carcinoma (SCLC), sarcomas, and others.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/